Bicycle Therapeutics plc (BCYC)
NASDAQ: BCYC · Real-Time Price · USD
4.690
-0.080 (-1.68%)
At close: Apr 28, 2026, 4:00 PM EDT
4.660
-0.030 (-0.64%)
After-hours: Apr 28, 2026, 4:42 PM EDT
Bicycle Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | 72.59 | 35.28 | 26.98 | 14.46 | 11.7 | |
| Revenue Growth (YoY) | 105.77% | 30.76% | 86.52% | 23.65% | 12.58% | |
| Cost of Revenue | 229.08 | 164.86 | 147.65 | 81.61 | 44.88 | |
| Gross Profit | -156.5 | -129.59 | -120.68 | -67.15 | -33.18 | |
| Selling, General & Admin | 86.37 | 79.19 | 69.27 | 49.51 | 32.44 | |
| Operating Expenses | 86.37 | 79.19 | 69.27 | 49.51 | 32.44 | |
| Operating Income | -242.87 | -208.77 | -189.95 | -116.65 | -65.62 | |
| Interest Expense | -0.21 | -1.73 | -3.26 | -3.34 | -2.98 | |
| Interest & Investment Income | 28.46 | 34.28 | 14 | 5.76 | 0.12 | |
| EBT Excluding Unusual Items | -214.61 | -176.22 | -179.21 | -114.24 | -68.48 | |
| Other Unusual Items | -4.2 | 2.42 | - | - | - | |
| Pretax Income | -218.81 | -173.8 | -179.21 | -114.24 | -68.48 | |
| Income Tax Expense | 0.15 | -4.77 | 1.46 | -1.52 | -1.66 | |
| Net Income | -218.96 | -169.03 | -180.66 | -112.72 | -66.82 | |
| Net Income to Common | -218.96 | -169.03 | -180.66 | -112.72 | -66.82 | |
| Shares Outstanding (Basic) | 69 | 58 | 36 | 30 | 25 | |
| Shares Outstanding (Diluted) | 69 | 58 | 36 | 30 | 25 | |
| Shares Change (YoY) | 19.02% | 63.54% | 20.00% | 18.35% | 30.90% | |
| EPS (Basic) | -3.16 | -2.90 | -5.08 | -3.80 | -2.67 | |
| EPS (Diluted) | -3.16 | -2.90 | -5.08 | -3.80 | -2.67 | |
| Free Cash Flow | -252.03 | -165.96 | -63.56 | -105.1 | -16.82 | |
| Free Cash Flow Per Share | -3.64 | -2.85 | -1.79 | -3.54 | -0.67 | |
| Gross Margin | -215.60% | - | - | - | -283.69% | |
| Operating Margin | -334.59% | -591.84% | -704.13% | -806.56% | -560.98% | |
| Profit Margin | -301.66% | -479.18% | -669.72% | -779.35% | -571.25% | |
| Free Cash Flow Margin | -347.21% | -470.47% | -235.61% | -726.67% | -143.83% | |
| EBITDA | -236.44 | -201.6 | -183.4 | -112.96 | -64.21 | |
| D&A For EBITDA | 6.42 | 7.17 | 6.55 | 3.69 | 1.41 | |
| EBIT | -242.87 | -208.77 | -189.95 | -116.65 | -65.62 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.